20 May 2013
Keywords: merck, kgaa, discontinues, sarizotan, after, drug, misses
Article | 03 July 2006
German drugmaker Merck KGaA says it will discontinue the development of its drug candidate sarizotan after it failed to demonstrate ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 July 2006
17 May 2013
© 2013 thepharmaletter.com